Skip to content

Management of Chronic Subdural Hematoma in Thrombocytopenia: Middle Meningeal Artery Embolization - Based Strategies Versus Medical Management or Surgery Alone.

Oct 2026 · AJNR. American journal of neuroradiology · 0 citations
Medicine

Abstract

Background

Thrombocytopenia complicates management of chronic subdural hematoma (cSDH), but no study has compared middle meningeal artery embolization (MMAE) with surgery or medical management in this population. We evaluated MMAE-containing strategies versus medical management or surgery alone in cSDH with platelets below 100×103/µL.

Methods

Using the TriNetX Research Network, we identified adults with cSDH and platelets below 100×103/µL (or below 50×103/µL for the severe-thrombocytopenia analysis). We performed three propensity-score-matched comparisons: standalone MMAE versus medical management and surgery plus MMAE versus surgery alone at platelets <100×103/µL; and standalone MMAE versus medical management at platelets <50×103/µL. The primary outcome was 90-day all-cause mortality; the secondary outcome was surgical evacuation (a composite of surgical evacuation or mortality at platelets <50×103/µL).

Results

After matching, cohorts ranged from 147 to 373 patients per group (standardized mean differences below 0.10 for nearly all covariates). At platelets <100×103/µL, standalone MMAE was associated with lower mortality than medical management (26.9% vs 37.3% hazard ratio 0.65 [95% CI 0.50-0.85]), and surgery plus MMAE was associated with lower mortality than surgery alone (20.5% vs 30.7%; hazard ratio 0.61 [95% CI 0.38-0.97]). At platelets <50×103/µL, the mortality comparison between standalone MMAE and medical management did not reach significance (34.2% vs 44.0%; hazard ratio 0.72 [95% CI 0.49-1.05]). Subsequent surgical evacuation did not differ significantly in any comparison.

Conclusions

For patients with cSDH and thrombocytopenia, management strategies incorporating MMAE were associated with lower 90-day mortality than medical management or surgery alone. Prospective confirmation is needed, including in severe thrombocytopenia, where the mortality comparison did not reach significance.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.